Sung Soo-Hyun, Sung Angela-Dong-Min, Sung Hyun-Kyung, An Tteul-E-Bom, Kim Kyeong Han, Park Jang-Kyung
Department of Pathology, College of Korean Medicine, Dae-gu Haany University, Daegu 38610, Republic of Korea.
Department of Preventive Medicine, College of Korean Medicine, Sangji University, Wonju 26339, Republic of Korea.
Evid Based Complement Alternat Med. 2018 Sep 27;2018:9415897. doi: 10.1155/2018/9415897. eCollection 2018.
This systematic review and meta-analysis aims to evaluate the current evidence from randomized controlled trials (RCTs) related to the effectiveness and safety of acupuncture treatment (AT), including electroacupuncture or thread-embedding therapy in combination with modern technology, for chronic pelvic pain (CPP) in women.
We searched 12 electronic databases up to December 2017. All randomized controlled trials evaluating the effect of AT for CPP were considered.
Four RCTs with 474 participants were included. The methodological quality of included studies was generally low. The results of meta-analysis of two studies showed that AT combined with conventional treatment (CT) was associated with significantly reduced CPP, based on the total effectiveness rate (n=277, mean difference = 1.29, confidence interval = 1.13 to 1.47, P=0.0001, I = 0%).
This review suggests the potential of AT combined with CT compared to CT alone for treating female CPP. However, there is insufficient evidence to conclude that AT can be recommended as a complementary and alternative (CAM) treatment for women with CPP. To draw a firm conclusion, future studies should require not only lager, more rigorously designed RCTs but also research on different AT types.
This study is registered with PROSPERO 2018 (CRD42018088627).
本系统评价和荟萃分析旨在评估来自随机对照试验(RCT)的现有证据,这些证据与针刺治疗(AT)(包括电针或埋线疗法结合现代技术)对女性慢性盆腔疼痛(CPP)的有效性和安全性相关。
我们检索了截至2017年12月的12个电子数据库。纳入所有评估AT对CPP疗效的随机对照试验。
纳入了4项随机对照试验,共474名参与者。纳入研究的方法学质量普遍较低。两项研究的荟萃分析结果显示,基于总有效率(n = 277,平均差 = 1.29,置信区间 = 1.13至1.47,P = 0.0001,I = 0%),AT联合传统治疗(CT)与CPP显著减轻相关。
本综述表明,与单独使用CT相比,AT联合CT治疗女性CPP具有潜在优势。然而,尚无足够证据得出AT可被推荐作为CPP女性的补充和替代(CAM)治疗方法的结论。为得出确切结论,未来研究不仅需要更大规模、设计更严谨的随机对照试验,还需要对不同类型的AT进行研究。
本研究已在PROSPERO 2018(CRD42018088627)注册。